Metabolic pathway alterations that support: Cell Proliferation

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 76, Issue , 2011, Pages 325-334

  Heiden Vander, M G ^a,b   Lunt, S Y ^a   Dayton, T L ^a   Fiske, B P ^a   Israelsen, W J ^a   Mattaini, K R ^a   Vokes, N I ^a   Stephanopoulos, G ^c   Cantley, L C ^d   Metallo, C M ^c,e   Locasale, J W ^d  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ACETYL COENZYME A; CARBON; GLUCOSE; GLUTAMINE; OXYGEN; PHOSPHOENOLPYRUVATE; PHOSPHOGLYCERATE MUTASE; PYRUVATE KINASE; SERINE; ADENOSINE TRIPHOSPHATE; PHOSPHOGLYCERATE DEHYDROGENASE; VON HIPPEL LINDAU PROTEIN;

AEROBIC METABOLISM; ARTICLE; CANCER CELL; CATABOLISM; CELL GROWTH; CELL MEMBRANE; CELL METABOLISM; CELL PROLIFERATION; CELL TRANSFORMATION; CITRIC ACID CYCLE; ENVIRONMENTAL FACTOR; GENE AMPLIFICATION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOLYSIS; HOMEOSTASIS; HUMAN; LIPOGENESIS; METABOLIC REGULATION; NONHUMAN; NUCLEIC ACID SYNTHESIS; OXIDATIVE PHOSPHORYLATION; PENTOSE PHOSPHATE CYCLE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; AEROBIC GLYCOLYSIS; AMINO ACID METABOLISM; BIOSYNTHESIS; ENZYME ACTIVITY; ENZYME REGULATION; PROTEIN DEPLETION; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; GLUCOSE; GLUTAMINE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; PYRUVATE KINASE; SERINE;

EID: 84865169609     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2012.76.010900     Document Type: Article

References (42)

1. Boros LG, Lee PW, Brandes JL, Cascante M, Muscarella P, Schirmer WJ, Melvin WS, Ellison EC. 1998. Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: Is cancer a disease of cellular glucose metabolism? Med Hypotheses 50: 55-59.
2. Boros LG, Torday JS, Lim S, Bassilian S, Cascante M, Lee WN. 2000. Transforming growth factor b2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res 60: 1183-1185.
3. Cairns RA, Harris IS, Mak TW. 2011. Regulation of cancer cell metabolism. Nat Rev Cancer 11: 85-95.
4. Cho J, King JS, Qian X, Harwood AJ, Shears SB. 2008. Dephosphorylation of 2,3-bisphosphoglycerate by MIPP expands the regulatory capacity of the Rapoport-Luebering glycolytic shunt. Proc Natl Acad Sci 105: 5998-6003.
5. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. 2008a. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233.
6. Christofk HR, Vander HeidenMG, Wu N, Asara JM, Cantley LC. 2008b. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452: 181-186.
7. Dang CV. 2010. Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? Cell Cycle 9: 3884-3886.
8. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. 2007. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci 104: 19345-19350.
9. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. 2008. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7: 11-20.
10. de Koning TJ, Snell K, Duran M, Berger R, Poll-The BT, Surtees R. 2003. L-Serine in disease and development. Biochem J 371: 653-661.
11. Dombrauckas JD, Santarsiero BD, Mesecar AD. 2005. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 44: 9417-9429.
12. Fang M, Shen Z, Huang S, Zhao L, Chen S, Mak TW, Wang X. 2010. The ER UDPase ENTPD5 promotes protein N-glycosylation, theWarburg effect, and proliferation in the PTEN pathway. Cell 143: 711-724.
13. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB. 2005. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8: 311-321.
14. Kaelin WG Jr. 2008. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 8: 865-873.
15. Kaelin WG Jr, Ratcliffe PJ. 2008. Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell 30: 393-402.
16. Kilburn DG, Lilly MD, Webb FC. 1969. The energetics of mammalian cell growth. J Cell Sci 4: 645-654.
17. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. 2006. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177-185.
18. Koppenol WH, Bounds PL, Dang CV. 2011. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11: 325-337.
19. Lehninger AL, Nelson DL, Cox MM. 1993. Principles of biochemistry. Worth, New York. Levine AJ, Puzio-Kuter AM. 2010. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330: 1340-1344.
20. Locasale JW, Cantley LC. 2010. Altered metabolism in cancer. BMC Biol 8: 88.
21. Locasale JW, Cantley LC, Vander Heiden MG. 2009. Cancer's insatiable appetite. Nat Biotechnol 27: 916-917.
22. Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, et al. 2011. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 43: 869-874.
23. Lunt SY, Vander Heiden MG. 2011. Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27: 441-464.
24. Mazurek S. 2010. Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 43: 969-980.
25. Menendez JA, Lupu R. 2007. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7: 763-777.
26. Metallo CM, Vander Heiden MG. 2010. Metabolism strikes back: Metabolic flux regulates cell signaling. Genes Dev 24: 2717-2722.
27. Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, Jewell CM, Johnson ZR, Irvine DJ, Guarente L, et al. 2011. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature doi: 10.1038/nature10602.
28. Ookhtens M, Kannan R, Lyon I, Baker N. 1984. Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiol 247: R146-R153.
29. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. 2006. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187-197.
30. Pfeiffer T, Schuster S, Bonhoeffer S. 2001. Cooperation and competition in the evolution of ATP-producing pathways. Science 292: 504-507.
31. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, et al. 2011. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476: 346-350.
32. Scholnick P, Lang D, Racker E. 1973. Regulatory mechanisms in carbohydrate metabolism. IX. Stimulation of aerobic glycolysis by energy-linked ion transport and inhibition by dextran sulfate. J Biol Chem 248: 5175.
33. Takenaka M, Yamada K, Lu T, Kang R, Tanaka T, Noguchi T. 1996. Alternative splicing of the pyruvate kinase M gene in a minigene system. Eur J Biochem 235: 366-371.
34. Vander Heiden MG. 2011. Targeting cancer metabolism: A therapeutic window opens. Nat Rev Drug Discov 10: 671-684.
35. Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324: 1029-1033.
36. Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron GJ, Amador-Noguez D, Christofk HR, Wagner G, Rabinowitz JD, Asara JM, et al. 2010. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329: 1492-1499.
37. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. 2009. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324: 1076-1080.
38. Wellen KE, Lu C, Mancuso A, Lemons JM, Ryczko M, Dennis JW, Rabinowitz JD, Coller HA, Thompson CB. 2010. The hexosamine biosynthetic pathway couples growth factorinduced glutamine uptake to glucose metabolism. Genes Dev 24: 2784-2799.
39. Yoo H, Stephanopoulos G, Kelleher JK. 2004. Quantifying carbon sources for de novo lipogenesis in wild-type and IRS-1 knockout brown adipocytes. J Lipid Res 45: 1324-1332.
40. Yoo H, Antoniewicz MR, Stephanopoulos G, Kelleher JK. 2008. Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line. J Biol Chem 283: 20621-20627.
41. Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.
42. Zu XL, Guppy M. 2004. Cancer metabolism: Facts, fantasy, and fiction. Biochem Biophys Res Commun 313: 459-465.